Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-200250
Filing Date
2024-08-14
Accepted
2024-08-14 08:00:58
Documents
2
Group Members
BCM EUROPE AGBELLEVUE CAPITAL MANAGEMENT LLCKUK HYOUN HWANG

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d820611dsc13ga.htm SC 13G/A 81308
2 EX-99.1 d820611dex991.htm EX-99.1 8618
  Complete submission text file 0001193125-24-200250.txt   91669
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Subject) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93996 | Film No.: 241204251
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 (425) 635-7700
Bellevue Global Life Science Investors LLC (Filed by) CIK: 0001953768 (see all company filings)

EIN.: 842636245 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A